Literature DB >> 1436033

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.

M M Shull1, I Ormsby, A B Kier, S Pawlowski, R J Diebold, M Yin, R Allen, C Sidman, G Proetzel, D Calvin.   

Abstract

Transforming growth factor-beta 1 (TGF-beta 1) is a multifunctional growth factor that has profound regulatory effects on many developmental and physiological processes. Disruption of the TGF-beta 1 gene by homologous recombination in murine embryonic stem cells enables mice to be generated that carry the disrupted allele. Animals homozygous for the mutated TGF-beta 1 allele show no gross developmental abnormalities, but about 20 days after birth they succumb to a wasting syndrome accompanied by a multifocal, mixed inflammatory cell response and tissue necrosis, leading to organ failure and death. TGF-beta 1-deficient mice may be valuable models for human immune and inflammatory disorders, including autoimmune diseases, transplant rejection and graft versus host reactions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1436033      PMCID: PMC3889166          DOI: 10.1038/359693a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  48 in total

1.  Expression and regulation of beta 7(beta p) integrins on mouse lymphocytes: relevance to the mucosal immune system.

Authors:  P J Kilshaw; S J Murant
Journal:  Eur J Immunol       Date:  1991-10       Impact factor: 5.532

2.  Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1.

Authors:  L D Johns; K C Flanders; G E Ranges; S Sriram
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

3.  Genetic control of B cell activation by bacterial lipopolysaccharide is mediated by multiple distinct genes or alleles.

Authors:  L M Glode; D L Rosenstreich
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

4.  Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells.

Authors:  P Matthys; R Dijkmans; P Proost; J Van Damme; H Heremans; H Sobis; A Billiau
Journal:  Int J Cancer       Date:  1991-08-19       Impact factor: 7.396

5.  Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-beta.

Authors:  J R Gamble; M A Vadas
Journal:  Science       Date:  1988-10-07       Impact factor: 47.728

6.  Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells.

Authors:  C W Czarniecki; H H Chiu; G H Wong; S M McCabe; M A Palladino
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

7.  Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.

Authors:  T Espevik; I S Figari; G E Ranges; M A Palladino
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

8.  Developmental expression of transforming growth factors alpha and beta in mouse fetus.

Authors:  J N Wilcox; R Derynck
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

9.  Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.

Authors:  J H Kehrl; A B Roberts; L M Wakefield; S Jakowlew; M B Sporn; A S Fauci
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

10.  Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation.

Authors:  S M Wahl; D A Hunt; H L Wong; S Dougherty; N McCartney-Francis; L M Wahl; L Ellingsworth; J A Schmidt; G Hall; A B Roberts
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

View more
  867 in total

1.  Non-redundant tumour supressor functions of transforming growth factor beta in breast cancer.

Authors:  M Azhar
Journal:  J Biosci       Date:  2001-03       Impact factor: 1.826

2.  Transforming growth factor beta1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans.

Authors:  P Robinson; P C Okhuysen; C L Chappell; D E Lewis; I Shahab; S Lahoti; A C White
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

3.  Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation.

Authors:  Mai-Lan N Huynh; Valerie A Fadok; Peter M Henson
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 4.  Advances in gene therapy of liver cirrhosis: a review.

Authors:  W J Dai; H C Jiang
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

5.  Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development.

Authors:  M Weinstein; S P Monga; Y Liu; S G Brodie; Y Tang; C Li; L Mishra; C X Deng
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

6.  TGF-beta is a critical mediator of acute lung injury.

Authors:  J F Pittet; M J Griffiths; T Geiser; N Kaminski; S L Dalton; X Huang; L A Brown; P J Gotwals; V E Koteliansky; M A Matthay; D Sheppard
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 7.  TGF-beta-mediated control of allergen-specific T-cell responses.

Authors:  Carsten B Schmidt-Weber; Steffen Kunzmann; Kurt Blaser
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

Review 8.  Maintenance and loss of self-tolerance in B cells.

Authors:  A Iglesias
Journal:  Springer Semin Immunopathol       Date:  2001-12

9.  TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation.

Authors:  C Fiocchi
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 10.  Latent-TGF-beta: an overview.

Authors:  D A Lawrence
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.